These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 11084461)
1. [Assessment of different histoprognosis grading systems for primary ovarian cancer: 100 patients given the same treatment for primary ovarian adenocarcinoma]. Penault-Llorca F; Levrel O; Clémenson A; Kwiatkowski F; Pomel C; Fouilhoux G; De Latour M; Curé H; Déchelotte P; Fonck Y; Dauplat J J Gynecol Obstet Biol Reprod (Paris); 2000 Oct; 29(6):548-54. PubMed ID: 11084461 [TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of early normalization of CA 125 during chemotherapy in stages III and IV ovarian tumors]. Ferrero JM; Largillier R; Ramaioli A; Heudier P; Teissier E; Namer M Bull Cancer; 1997 Jul; 84(7):722-8. PubMed ID: 9339198 [TBL] [Abstract][Full Text] [Related]
3. Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features--problems involved in the architectural grading system. Shimizu Y; Kamoi S; Amada S; Hasumi K; Akiyama F; Silverberg SG Gynecol Oncol; 1998 Jul; 70(1):2-12. PubMed ID: 9698465 [TBL] [Abstract][Full Text] [Related]
4. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma. Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146 [TBL] [Abstract][Full Text] [Related]
5. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Erzen M; Rakar S; Klancnik B; Syrjänen K Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420 [TBL] [Abstract][Full Text] [Related]
7. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Gilks CB; Ionescu DN; Kalloger SE; Köbel M; Irving J; Clarke B; Santos J; Le N; Moravan V; Swenerton K; Hum Pathol; 2008 Aug; 39(8):1239-51. PubMed ID: 18602670 [TBL] [Abstract][Full Text] [Related]
8. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400 [TBL] [Abstract][Full Text] [Related]
9. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation. Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk. Hasegawa T; Yamamoto S; Yokoyama R; Umeda T; Matsuno Y; Hirohashi S Cancer; 2002 Aug; 95(4):843-51. PubMed ID: 12209729 [TBL] [Abstract][Full Text] [Related]
11. [Treatment and prognostic factors for stage IV epithelial ovarian cancer]. Wu M; Shen K; Lang J Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158 [TBL] [Abstract][Full Text] [Related]
12. [Construction and utilization of the prognostic model of serous ovarian adenocarcinoma]. Yang R; Feng J; Fang XZ; Bai F; Cheng YX; Liu C; Zhu W; Li L Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):459-63. PubMed ID: 17083811 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC; Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296 [TBL] [Abstract][Full Text] [Related]
14. Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum. Seidman JD; Horkayne-Szakaly I; Cosin JA; Ryu HS; Haiba M; Boice CR; Yemelyanova AV Gynecol Oncol; 2006 Nov; 103(2):703-8. PubMed ID: 16828848 [TBL] [Abstract][Full Text] [Related]
15. Quantitative prognostic features in FIGO I ovarian cancer patients without postoperative treatment. Brugghe J; Baak JP; Wiltshaw E; Brinkhuis M; Meijer GA; Fisher C Gynecol Oncol; 1998 Jan; 68(1):47-53. PubMed ID: 9454660 [TBL] [Abstract][Full Text] [Related]
16. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma. Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832 [TBL] [Abstract][Full Text] [Related]
17. [Survival of cervical cancer patients in selected regions of Poland in 1990-1996, in relation to some prognostic factors]. Bielska-Lasota M; Krynicki R; Rabczenko D; Czerw-Głab K; Starzewski J; Wronkowski Z; Zieliński J; Chil A; Hudała-Klecha J; Swiercz A Przegl Epidemiol; 2004; 58(3):523-36. PubMed ID: 15730017 [TBL] [Abstract][Full Text] [Related]
18. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy. Juretzka MM; Barakat RR; Chi DS; Iasonos A; Dupont J; Abu-Rustum NR; Poynor EA; Aghajanian C; Spriggs D; Hensley ML; Sabbatini P Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584 [TBL] [Abstract][Full Text] [Related]
19. The reproducibility of histological parameters employed in the novel binary grading systems of endometrial cancer. Gemer O; Uriev L; Voldarsky M; Gdalevich M; Ben-Dor D; Barak F; Anteby EY; Lavie O Eur J Surg Oncol; 2009 Mar; 35(3):247-51. PubMed ID: 18775628 [TBL] [Abstract][Full Text] [Related]
20. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]